Page last updated: 2024-08-17

medroxyprogesterone acetate and Infusion Site Adverse Event

medroxyprogesterone acetate has been researched along with Infusion Site Adverse Event in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dahmke, H; Damke, B; Jödicke, AM; Kullak-Ublick, GA; Schäublin, M; Weiler, S1

Other Studies

1 other study(ies) available for medroxyprogesterone acetate and Infusion Site Adverse Event

ArticleYear
Severe injection site reactions after subcutaneous administration of Sayana©.
    Swiss medical weekly, 2017, Volume: 147

    Topics: Adverse Drug Reaction Reporting Systems; Databases, Factual; Female; Humans; Injection Site Reaction; Injections, Subcutaneous; Lipodystrophy; Medroxyprogesterone Acetate; Pharmacovigilance; Retrospective Studies

2017